Table 1.
Parameters | Saline | wt CVB3 | pBRCVB3 | Mt 2 | Mt 3 | Mt 4 | Mt 8 | Mt 10 |
---|---|---|---|---|---|---|---|---|
Heart | ||||||||
Incidence | 0/9 (0.0) | 10/10 (100.0) | 8/10 (80.0) | 0/9 (0.0) | 2/9 (22.0) | 3/9 (33.3) | 1/16 (6.3) | 0/9 (0.0) |
Mortality | 0/9 (0.0) | 10/10 (100.0) | 2/10 (20.0) | 0/9 (0.0) | 0/9 (0.0) | 1/9 (11.1) | 0/16 (0.0) | 0/9 (0.0) |
Myocardial lesions | 0.0 (0.0)a | 34.2 ± 13.4 | 11.8 ± 7.3 | 0.0 (0.0)a | 0.2 ± 0.1a | 0.4 ± 0.3a | 0.1 ± 0.1a | 0.0 (0.0)a |
Pancreas | ||||||||
Incidence | 0/9 (0.0)a | 10/10 (100.0) | 10/10 (100.0) | 8/9 (88.8) | 9/9 (100.0) | 5/9 (55.5) | 5/16 (31.2)b | 0/9 (0.0)a |
Atrophy | 0 (0.0)a | 10/10 (100.0) | 9/10 (90.0) | 8/9 (88.8) | 9/9 (100.0) | 5/9 (55.5) | 1/16 (6.3)a | 0 (0.0)a |
Inflammation | 0 (0.0)a | 10/10 (100.0) | 10/10 (100.0) | 8/9 (88.8) | 9/9 (100.0) | 5/9 (55.5) | 5/16 (31.2)b | 0 (0.0)a |
Necrosis | 0 (0.0)a | 9/10 (90.0) | 8/10 (80.0) | 4/9 (44.4) | 6/9 (66.6) | 3/9 (33.3)b | 0/16 (0.0)a | 0 (0.0)a |
Mineralization | 0 (0.0)a | 8/10 (80.0) | 7/10 (70.0) | 3/9 (33.3)b | 6/9 (66.6) | 2/9 (22.2)b | 0/16 (0.0)a | 0 (0.0)a |
() Indicates percentages.
aDenotes significant differences in comparison with wt CVB3 and pBRCVB3 group (p < 0.001).
bDenotes significant differences in comparison with wt CVB3 and pBRCVB3 group (p < 0.05).